4-乙基-1,4-苯并恶嗪-3-酮 | 23863-09-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 中文名称: 4-乙基-1,4-苯并恶嗪-3-酮
• 英文名称: 4-ethyl-2H-1,4-benzoxazine-3(4H)-one
• 英文别名: 4-Aethyl-1,4-benzoxazin-3-on；4-ethyl-4H-benzo[1,4]oxazin-3-one；4-ethyl-4H-benz[1,4]oxazin-3-one；4-Aethyl-4H-benz[1,4]oxazin-3-on；2H-1,4-Benzoxazin-3(4H)-one, 4-ethyl-；4-ethyl-1,4-benzoxazin-3-one
• CAS: 23863-09-4
• 化学式: C₁₀H₁₁NO₂
• mdl: MFCD11896394
• 分子量: 177.203
• InChiKey: CRBVBCJIYONNNP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-乙基-1,4-苯并恶嗪-3-酮 在 lithium aluminium tetrahydride 作用下， 生成 4-ethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
  参考文献：
  名称：

  Maillard,J. et al., Chimica Therapeutica, 1969, vol. 4, p. 80 - 88

  摘要：

  DOI：
• 作为产物：
  描述：

  2H-1,4-苯并噁嗪-3(4H)-酮 、 溴乙烷 在 sodium hydroxide 、 苄基三乙基氯化铵 、 silica gel 作用下， 以 乙腈 为溶剂， 反应 0.17h， 以81%的产率得到4-乙基-1,4-苯并恶嗪-3-酮
  参考文献：
  名称：

  RAPID N-ALKYLATION OF BENZOXAZINONES AND BENZOTHIAZINONES UNDER MICROWAVE IRRADIATION

  摘要：

  DOI：

  10.1080/00304949609355917

文献信息

• 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS
  申请人：Hunziker Daniel

  公开号：US20100249124A1

  公开（公告）日：2010-09-30

  The present invention relates to compounds of formula I wherein R 1a to R 1c , R 2 , R 3 and R 5 are as defined in the description and claims and R 4 signifies a bicyclic heteroaryl group or a cyanophenyl group, as well as pharmaceutically acceptable salts thereof. The compounds are glucocorticoid receptor antagonists useful for the treatment and/or prevention of diseases such as diabetes, dyslipidemia, obesity, hypertension, cardiovascular diseases, adrenal imbalance or depression.

  本发明涉及式I的化合物，其中R1a至R1c，R2，R3和R5如描述和权利要求中定义，R4表示双环杂芳基或氰苯基，以及其药学上可接受的盐。这些化合物是糖皮质激素受体拮抗剂，可用于治疗和/或预防疾病，如糖尿病、血脂异常、肥胖、高血压、心血管疾病、肾上腺失调或抑郁症。
• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2004069823A1

  公开（公告）日：2004-08-19

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  该发明涉及抑制组蛋白去乙酰化酶的技术。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病症的组合物和方法。
• 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
  申请人：Hoffmann-La Roche Inc.

  公开号：US08268820B2

  公开（公告）日：2012-09-18

  The present invention relates to compounds of formula I wherein R1a to R1c, R2, R3 and R5 are as defined in the description and claims and R4 signifies a bicyclic heteroaryl group or a cyanophenyl group, as well as pharmaceutically acceptable salts thereof. The compounds are glucocorticoid receptor antagonists useful for the treatment and/or prevention of diseases such as diabetes, dyslipidemia, obesity, hypertension, cardiovascular diseases, adrenal imbalance or depression.

  本发明涉及以下式子的化合物：其中R1a至R1c、R2、R3和R5如说明书和权利要求中所定义，R4表示双环杂芳基或氰基苯基，以及其药学上可接受的盐。这些化合物是糖皮质激素受体拮抗剂，可用于治疗和/或预防糖尿病、血脂异常、肥胖症、高血压、心血管疾病、肾上腺失调或抑郁症等疾病。
• N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE
  申请人：Suetsugu Satoshi

  公开号：US20120122773A1

  公开（公告）日：2012-05-17

  The present invention provides a compound of formula (I): wherein R 1a is optionally substituted C 1-6 alkyl, etc.; R 1m is hydrogen atom, etc.; G 1 , G 2 , G 3 and G 4 are (i), etc. ((i) G 1 is —N(R 1b )—, G 2 is —CO—, G 3 is —C(R 1c )(R 1d )—, and G 4 is oxygen, etc.); R 1b is optionally substituted C 1-6 alkyl, etc.; R 1c and R 1d are each independently optionally substituted C 1-6 alkyl, etc.; R 2 is optionally substituted C 1-6 alkyl, etc.; R 3a , R 3b , R 3c and R 3d are each independently a group: -A-B (A is a single bond, etc., B is hydrogen atom, etc.), etc.; n is 1, etc.; R 5 is C 1-4 alkoxycarbonyl, etc., or a pharmaceutically acceptable salt thereof, which is useful as a renin inhibitor.

  本发明提供了一种化合物，其化学式为(I)：其中R1a是可选取代的C1-6烷基等；R1m是氢原子等；G1，G2，G3和G4是(i)等，((i) G1是—N(R1b)—，G2是—CO—，G3是—C(R1c)(R1d)—，G4是氧原子等)；R1b是可选取代的C1-6烷基等；R1c和R1d分别独立地是可选取代的C1-6烷基等；R2是可选取代的C1-6烷基等；R3a、R3b、R3c和R3d分别独立地是一种基团：-A-B（其中A是单键等，B是氢原子等）等；n是1等；R5是C1-4烷氧羰基等，或其药学上可接受的盐，其作为一种肾素抑制剂是有用的。
• Method for the Synthesis of 2H-1,4-Benzoxazin-3-(4H)-ones via Ligand-Free Copper-Catalyzed Cascade Reaction
  作者：Songlin Zhang、Lingyu Zhang

  DOI：10.1055/a-2110-1989

  日期：2023.10

  An efficient method for the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones via ligand-free copper-catalyzed cascade reaction of substituted chloroacetamides with 2-halophenols has been developed for the first time. Some of the issues typically encountered during the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones, including adding noble metals and ligands, poor substrate scope, have been addressed using this

  首次开发了一种通过取代氯乙酰胺与2-卤代酚的无配体铜催化级联反应合成2 H -1,4-苯并恶嗪-3-(4 H )-酮的有效方法。使用这种新开发的无配体铜，可以解决在2 H -1,4-苯并恶嗪-3-(4 H )-one合成过程中通常遇到的一些问题，包括添加贵金属和配体、底物范围差等-催化级联反应。